Case represents the first time hydrocephalus has been successfully treated using a minimally-invasive endovascular procedure BOSTON, Dec. 7, 2021 /PRNewswire/ — CereVasc, Inc., a clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, announced today the publication of a case report detailing the first treatment in a study of […]

Investigational device has the potential to transform a half-century-old standard of care BOSTON, Feb. 10, 2021 /PRNewswire/ — CereVasc, Inc., a clinical-stage, medical device company developing novel, minimally invasive treatments for neurological diseases, has treated the first patient in a study of its eShunt System, an investigational device intended to treat communicating […]